These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23931957)

  • 41. Australia's response to HIV among people who inject drugs.
    Madden A; Wodak A
    AIDS Educ Prev; 2014 Jun; 26(3):234-44. PubMed ID: 24846486
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence-based policy-making: the implications of globally-applicable research for context-specific problem-solving in developing countries.
    Behague D; Tawiah C; Rosato M; Some T; Morrison J
    Soc Sci Med; 2009 Nov; 69(10):1539-46. PubMed ID: 19781839
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Critical Analysis of Representations of Inequalities in Childhood Obesity in Australian Health Policy Documents.
    Chung A; Zorbas C; Peeters A; Backholer K; Browne J
    Int J Health Policy Manag; 2022 Sep; 11(9):1767-1779. PubMed ID: 34380204
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Generic drug prices and policy in Australia: room for improvement? a comparative analysis with England.
    Mansfield SJ
    Aust Health Rev; 2014 Feb; 38(1):6-15. PubMed ID: 24480618
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Measuring research influence on drug policy: a case example of two epidemiological monitoring systems.
    Ritter A; Lancaster K
    Int J Drug Policy; 2013 Jan; 24(1):30-7. PubMed ID: 22503108
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Equality and difference: persisting historical themes in health and alcohol policies affecting Indigenous Australians.
    Brady M
    J Epidemiol Community Health; 2007 Sep; 61(9):759-63. PubMed ID: 17699528
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Australian pharmaceutical policy: price control, equity, and drug innovation in Australia.
    Doran E; Alexander Henry D
    J Public Health Policy; 2008 Apr; 29(1):106-20. PubMed ID: 18368023
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Australia's National Medicines Policy is outdated and in need of review.
    Shaw B; Chisholm O
    Med J Aust; 2019 Sep; 211(6):252-254.e1. PubMed ID: 31327165
    [No Abstract]   [Full Text] [Related]  

  • 51. Evaluating Australia's National Medicines Policy using geographical mapping.
    Roughead EE; Monteith GR; Harvey KJ; Tett SE
    Intern Med J; 2002 Mar; 32(3):66-71. PubMed ID: 11885845
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Problems, policies and politics: making the case for better assistive technology provision in Australia.
    Layton N
    Disabil Rehabil Assist Technol; 2015 May; 10(3):240-4. PubMed ID: 24524441
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recognizing rhetoric in health care policy analysis.
    Russell J; Greenhalgh T; Byrne E; McDonnell J
    J Health Serv Res Policy; 2008 Jan; 13(1):40-6. PubMed ID: 18325155
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Real or perceived impediments to minimum pricing of alcohol in Australia: public opinion, the industry and the law.
    Chalmers J; Carragher N; Davoren S; O'Brien P
    Int J Drug Policy; 2013 Nov; 24(6):517-23. PubMed ID: 23773685
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Australia's 'fourth hurdle' drug review comparing costs and benefits holds lessons for the United States.
    Lopert R; Elshaug AG
    Health Aff (Millwood); 2013 Apr; 32(4):778-87. PubMed ID: 23569059
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Policy scorecard for gender mainstreaming: gender equity in health policy.
    Keleher H
    Aust N Z J Public Health; 2013 Apr; 37(2):111-7. PubMed ID: 23551468
    [TBL] [Abstract][Full Text] [Related]  

  • 58. History Matters: The Critical Contribution of Historical Analysis to Contemporary Health Policy and Health Care.
    Sheard S
    Health Care Anal; 2018 Jun; 26(2):140-154. PubMed ID: 29063364
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The place of race and racism in cultural competence: what can we learn from the English experience about the narratives of evidence and argument?
    Bhui K; Ascoli M; Nuamh O
    Transcult Psychiatry; 2012 Apr; 49(2):185-205. PubMed ID: 22421685
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methadone, a contested substance: Danish methadone policy in the 1970s.
    Houborg E
    Int J Drug Policy; 2013 Nov; 24(6):e73-80. PubMed ID: 24120441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.